Bayer and MOMA Therapeutics enter collaboration and license agreement in Oncology

Companies will collaborate to develop a high-value small molecule program, further enhancing Bayer’s precision oncology development portfolio / MOMA will receive an upfront payment and collaboration fee and is eligible to receive near-term discovery,…

2 Min
More

Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Su

Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today announced a new global clinical supply agreement.…

1 Min
More

New study: Mental Health in Real Time

Constant changes in our world often lead to experiencing stress. This can negatively affect our health. However, many people do not even realize that they are in a state of stress.

1 Min
More

Pentixapharm Holding AG Completes IPO in the Prime Standard of the Frankfurt Stock Exchange

Pentixapharm Holding AG (“Pentixapharm”) made its debut today in the Prime Standard of the Frankfurt Stock Exchange under the ticker symbol PTP and the international securities identification number (ISIN) DE000A40AEG0. The initial trading price was…

3 Min
More

Special Topic | Breast Cancer Awareness Month October

Breast cancer is the most common type of cancer in women. During Breast Cancer Awareness Month in October, people around the world are informed about the disease, the situation of women and prevention options. In Berlin-Brandenburg, this topic is…

11 Min
More

Caresyntax Awarded 2024 German AI Prize for Advancing Surgical Intelligence

Caresyntax, a leader in surgical intelligence and automation, has been awarded the prestigious 2024 German AI Prize. The awards were presented by Volker Wissing, Germany’s Federal Minister for Digitalization, at a ceremony held in Berlin on…

2 Min
More

In Portrait | Cambrium: New materials with the aid of AI

The Berlin-based start-up Cambrium uses artificial intelligence to produce bio-based materials. The materials are sustainable and above all - depending on the use case - adaptable to the respective purpose.

4 Min
More

2nd NUVISAN DRUG DISCOVERY INNOVATION CHALLENGE

Orphan Diseases and Challenging Targets

 

Collaborate with venture capital and scientific experts for your drug discovery projects

1 Min
More

Interview | Prof. Dr. Martin Gersch, Freie Universität Berlin School of Business & EconomicsDepartment of Information Systems, Professor of Business Administration, Health-X Innovation Hub

Connected, comprehensive and always available – the future of health data

6 Min
More

Noah Labs receives €3 million in financing round lead by Nina Capital

Noah Labs, a Berlin and Potsdam-based digital health startup focused on AI-powered telemonitoring for patients with heart failure, has successfully closed a seed funding round of €3 million. Lead investor Nina Capital from Barcelona a dedicated…

3 Min
More
Show more items